Neuronetics, Inc.
STIM
$1.24
-$0.04-3.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 151.64M | 149.16M | 129.87M | 111.11M | 89.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 151.64M | 149.16M | 129.87M | 111.11M | 89.45M |
| Cost of Revenue | 78.51M | 76.45M | 63.78M | 48.12M | 32.04M |
| Gross Profit | 73.12M | 72.71M | 66.10M | 62.99M | 57.41M |
| SG&A Expenses | 95.81M | 97.16M | 92.67M | 89.06M | 83.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 180.65M | 180.19M | 167.14M | 148.78M | 127.57M |
| Operating Income | -29.02M | -31.04M | -37.27M | -37.67M | -38.12M |
| Income Before Tax | -37.23M | -39.14M | -44.61M | -48.55M | -48.54M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -37.23 | -39.14 | -44.61 | -48.55 | -48.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 113.00K | 137.00K | 108.00K | -248.00K | 33.00K |
| Net Income | -37.11M | -39.00M | -44.50M | -48.80M | -48.51M |
| EBIT | -29.02M | -31.04M | -37.27M | -37.67M | -38.12M |
| EBITDA | -25.78M | -27.63M | -34.21M | -34.99M | -35.79M |
| EPS Basic | -0.55 | -0.60 | -0.84 | -1.15 | -1.32 |
| Normalized Basic EPS | -0.33 | -0.37 | -0.51 | -0.62 | -0.72 |
| EPS Diluted | -0.55 | -0.60 | -0.84 | -1.15 | -1.32 |
| Normalized Diluted EPS | -0.33 | -0.37 | -0.51 | -0.62 | -0.72 |
| Average Basic Shares Outstanding | 271.83M | 263.71M | 231.63M | 194.59M | 158.46M |
| Average Diluted Shares Outstanding | 271.83M | 263.71M | 231.63M | 194.59M | 158.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |